Abstract:Although iodinated contrast agents are safe and widely used, adverse events occur and questions remain about their use, safety, and interactions. Some questions are easily answered and others still require extensive investigation. For one frequent question--is informed consent necessary before all contrast media injections--the simple answer is no. Another question concerns use of contrast media in patients with prior reactions or allergies. Contrast agents can be safely used in such patients, but special care must be taken to be aware of what the previous reaction was and to be ready to treat any reaction. The protective role of pre-treatment with steroids is well established for minor reactions, but they may not prevent major reactions. It is important to realize that even life-threatening, anaphylactoid reactions are not the result of a true allergy to contrast media. Many questions arise about contrast agent-induced nephropathy. Baseline serum creatinine values should be obtained in patients who are at risk, not all patients. The incidence and natural history of contrast agent-induced nephropathy remain unclear. It occurs only in patients with compromised renal function before contrast agent injection, but even patients with normal serum creatinine levels can have renal dysfunction. Calculated creatinine clearance is a better way to determine risk and to follow this complication. The outcome in almost all patients is benign, with progression to end-stage renal disease being rare. The major risk factors, in addition to renal dysfunction, are long-standing diabetes mellitus, dehydration, and use of other nephrotoxic medications. Recent work in preventing and ameliorating contrast agent-induced nephropathy with N-acetyl cysteine, substitution of an isosmolal nonionic contrast agent, and various hydration regimens has been promising. Another common concern is use of iodinated contrast agents in pregnant or breast-feeding women. In both cases, there is no evidence of harm to the fetus or infant, but it is prudent to weigh the theoretical risks and benefits and avoid contrast agent administration unless it is truly necessary.

Key Considerations regarding the Renal Risks of Iodinated Contrast Media: The Nephrologist's Role

Risk factors and recent advances in the prevention of contrast - induced nephropathy

Prevention of Contrast-Induced Acute Kidney Injury: an Update

Contrast medium induced acute kidney injury: a narrative review

Use of Intravenous Iodinated Contrast Media in Patients with Kidney Disease: Consensus Statements from the American College of Radiology and the National Kidney Foundation

Contrast-Induced Nephropathy: A Review of Mechanisms and Risks

Update on the renal toxicity of iodinated contrast drugs used in clinical medicine

Contrast-induced Nephropathy in CT: Incidence, Risk Factors and Strategies for Prevention.

Prevention of contrast-associated acute kidney injury in an era of increasingly complex interventional procedures

Contrast-associated Acute Kidney Injury: an Update of Risk Factors, Risk Factor Scores, and Preventive Measures

Unveiling the Mysteries of Contrast-Induced Acute Kidney Injury: New Horizons in Pathogenesis and Prevention

Contrast-induced acute kidney injury: a review of definition, pathogenesis, risk factors, prevention and treatment

Pharmacological interventions for the prevention of contrast-induced acute kidney injury in high-risk adult patients undergoing coronary angiography: a systematic review and meta-analysis of randomised controlled trials

Global Risk Factors of Contrast-Induced Acute Kidney Injury: Systematic Review and Meta-Analysis

Prevention and Management of Adverse Reactions Induced by Iodinated Contrast Media

Iodinated Contrast and Nephropathy: Does It Exist and What Is the Actual Evidence?

Current updates in radiocontrast-associated acute kidney injury

Frequently Asked Questions: Iodinated Contrast Agents

Contrast Induced Acute Kidney Injury (CI- AKI) - Myths and Realities

Safe Use of Contrast Media: What the Radiologist Needs to Know

Does safe dosing of iodinated contrast prevent contrast-induced acute kidney injury?